Introducing the Series: Voices from the Boardroom
Insights on Modern Corporate Governance from the Front Lines of Law, Business, and Life Sciences
By Al Parker
Over the course of a 30-year career at the intersection of law, business, and the life sciences industry, I’ve worn many hats—CEO, COO, Chief Legal Officer, board advisor, outside counsel, and independent director. I’ve worked alongside high-performing boards in times of steady growth, high-stakes transactions, regulatory pressure, and existential crisis. Through it all, one constant has emerged: the boardroom is where clarity, judgment, and trust matter most.
This blog series, Voices from the Boardroom, offers candid reflections on the evolving role of boards, drawn from real-world experience and governance engagements. It’s not a theoretical exercise—it’s grounded in the practical realities faced by directors and executives navigating complexity in regulated, high-innovation environments.
Across these posts, I’ll share insights on:
-
What board readiness really looks like—and what separates truly effective directors from merely well-credentialed ones
-
How boards can add value in industries like biotech, diagnostics, and therapeutics where the pace of change is constant
-
The difference between oversight and interference in governance-heavy environments
-
Navigating strategic risk, compliance, crisis, and long-term value creation from the board’s vantage point
These are not white papers. They are field notes—intended for current and aspiring directors, executive leaders, and anyone committed to better governance. My goal is to contribute to the broader conversation about what makes board service impactful, principled, and fit for the challenges ahead.
If you’re part of a board, advising one, or seeking a seat yourself, I invite you to follow along.
And if you’d like to learn more about my own board and governance background, you’ll find that here.
Next up: What Boardroom Readiness Really Looks Like: Lessons from the C-Suite.